Ashwagandha and Adaptogens: What the Research Actually Supports for Stressed Executives

No supplement category is marketed harder to stressed executives than adaptogens — and no category is more poorly understood by the people buying it. Ashwagandha gummies, rhodiola lattes, mushroom blends promising to "balance cortisol": the shelf space keeps growing while the actual evidence base stays narrow and specific. Some of these compounds have genuinely solid human trial data behind them. Most of the products built around them are underdosed, poorly sourced, or solving a problem that sleep and training would solve better. Here is how to tell the difference.

I'm Dr. Jason Rannfeldt, a health performance coach who works with founders, executives, and high performers on building stress resilience that holds up under real schedules. In this article I'll explain what adaptogens actually are, what the research supports for the two with real evidence — ashwagandha and rhodiola — who should avoid them, and the exact protocol I use when I do recommend them.

What an adaptogen actually is

The term "adaptogen" has a real definition, established by Soviet-era researchers and refined since: a compound that helps the body resist and adapt to stressors, normalizes physiological function rather than pushing it in one direction, and is non-toxic at normal doses. That definition matters because it excludes most of what gets marketed under the label. A true adaptogen does not sedate you like a sleeping pill or stimulate you like caffeine — it modulates the stress response system itself, primarily the hypothalamic-pituitary-adrenal axis that governs cortisol, which I covered in depth in Cortisol and Performance. By that standard, only a handful of compounds qualify with meaningful human evidence: ashwagandha, rhodiola rosea, and to a lesser extent holy basil and schisandra. The rest of the category is marketing.

Ashwagandha: the one with real data

Ashwagandha is the best-studied adaptogen by a wide margin, and its evidence base is legitimately interesting. Multiple randomized controlled trials using standardized extracts — most often KSM-66 or Sensoril — have found meaningful reductions in perceived stress and serum cortisol, typically in the range of 20 to 30 percent, at doses of 300 to 600 mg of extract daily over 8 to 12 weeks. Several trials also show improvements in sleep quality, which connects directly to the framework in Sleep Optimization for Executives, and modest improvements in strength and testosterone in stressed or training populations, relevant to Testosterone Optimization for Men Over 40. In my practice, ashwagandha is the adaptogen I reach for when a client's stress load is objectively high, sleep is suffering, and the lifestyle work is already in motion — it is an amplifier of the system in Stress Resilience and Nervous System Regulation for Executives, not a substitute for it.

Rhodiola: the fatigue and focus candidate

Rhodiola rosea has a thinner but still respectable evidence base, aimed at a different problem: fatigue and cognitive performance under stress. Trials using standardized extracts — typically 200 to 400 mg daily, standardized for rosavins and salidroside — have shown reductions in burnout symptoms and mental fatigue, including in physicians on night duty, which is about as close to an executive schedule as research gets. Where ashwagandha trends calming, rhodiola trends activating; I think of it as the better fit for the client whose stress presents as exhaustion and flat focus rather than wired anxiety — the pattern I dissected in The Afternoon Energy Crash and Deep Work and Cognitive Endurance for Executives. Timing matters: rhodiola goes in the morning, ashwagandha usually in the evening, and taking them backwards is a common self-sabotage.

The hype to ignore

Now the honesty. Most adaptogen products fail on one of three grounds. Dose. A gummy containing 50 mg of ashwagandha root powder is not the intervention studied in trials — the research uses 300 to 600 mg of concentrated, standardized extract. Standardization. The active compounds — withanolides in ashwagandha, rosavins and salidroside in rhodiola — vary wildly between products; if the label does not state the standardization, assume the worst. Kitchen-sink blends. Formulas combining eight adaptogens at sub-clinical doses each are designed for the label, not the outcome. This is the same discipline I apply across the cabinet in Supplements for Executives: one compound, clinical dose, verified quality, measured result.

Who should not take them

Adaptogens are not universally benign, and the contraindications are real. Ashwagandha can stimulate thyroid activity, so anyone with hyperthyroidism or on thyroid medication should only use it with their physician's oversight — and it should be paused before surgery and avoided in pregnancy. Rare cases of liver injury have been reported, which is one more reason to use reputable, tested brands and to cycle rather than run it indefinitely. Rhodiola can be too activating for people prone to anxiety or insomnia if taken late in the day, and it has mild blood-pressure and blood-sugar effects that matter for anyone on related medications — the populations I covered in Blood Pressure and Cardiovascular Health for Executives and Blood Sugar and Executive Focus. The rule I give every client: supplements layer onto a medical picture, they never ignore it.

The protocol I actually use

When I do recommend adaptogens, the protocol is deliberately boring. First, the foundations. No adaptogen outperforms the sleep architecture in The Executive's Evening Wind-Down, the training base in Strength Training After 40, or the stress-load audit in Stress Load: How to Audit and Reduce It — those come first, always. Second, one compound at a time. For the wired-and-tired client with poor sleep: ashwagandha, 300 to 600 mg of a standardized KSM-66 or Sensoril extract, taken with dinner, for 8 to 12 weeks. For the exhausted-and-flat client: rhodiola, 200 to 400 mg standardized extract, taken on waking. Third, measure. Track subjective stress and sleep scores weekly, and watch the objective trend in the wearable metrics from Recovery Metrics: HRV, RHR, and Sleep Score — if HRV and sleep scores do not move in 8 weeks, stop. Fourth, cycle. I typically run adaptogens in 8-to-12-week blocks with breaks, not as permanent fixtures. I wrote a shorter companion piece on stress supplements over at jasonleerannfeldt.me for readers who want the quick version.

What adaptogens will not fix

The most important section of this article is the limitation. If your cortisol is elevated because you sleep five hours, drink three coffees before noon, never train, and run a calendar with no recovery in it, ashwagandha will take the edge off and nothing more. The executives who get transformative results are the ones who fix the inputs — the caffeine timing in Caffeine and Executive Performance, the alcohol timing in Alcohol and Executive Performance, the morning light exposure in Morning Light and Circadian Performance — and then use adaptogens as a measured amplifier. Supplements multiply a system; they do not replace one.

The bottom line

Ashwagandha and rhodiola are real tools with real human evidence — for the right person, at the right dose, for a defined block of time, on top of solid foundations. Everything else in the adaptogen aisle is packaging. If you want your supplements, sleep, training, and stress load sequenced into one measured system built around your actual calendar, that is the work inside Crush 90 and Thrive 90, alongside the broader framework in Longevity Strategies for High Performers. Start with a short conversation on the contact page, or read more about the approach on the about page.